Natco Pharma gets zero USFDA observations for Chennai facility Medical Dialogues Bureau16 July 2019 4:00 AM GMTNatco Pharma announced "successful completion of regulatory inspection from the US Food and Drug Administration (USFDA) for its active pharmaceutical...
Sun Pharma enters licensing agreement with CMS for arthritis drug Tildrakizumab Medical Dialogues Bureau28 Jun 2019 7:00 AM GMTThe initial tenure of the agreement between Sun Pharma and CMS shall be 15 years from the first commercial sale of Tildrakizumab in Greater China and...
GSK to fund doctoral programs at Government established Regional Centre for Biotechnology Medical Dialogues Bureau27 Jun 2019 4:00 AM GMTUnder this initiative, the RCB will develop program content, manage logistics and oversee the running of the full-time programs while GSK...
Bristol-Myers to sell blockbuster Otezla for its $74 billion merger with Celgene Medical Dialogues Bureau26 Jun 2019 3:30 AM GMTBristol-Myers announced its plans to buy Celgene in a cash-and-stock deal in early January to bring together the companies that specialize in oncology...
Zydus Announces Completion of Enrolment in EVIDENCES IV Phase 2 Clinical Trial of Saroglitazar Magnesium in NASH Medical Dialogues Bureau19 Jun 2019 6:31 AM GMTAHMEDABAD: Zydus Cadila, an innovation-driven, global pharmaceutical company, announced that it has completed enrolment of 104 patients with...
Ressurecting Sun Pharma: Shanghvi committed to pharma business; surrenders NBFC licence Meghna A Singhania29 May 2019 9:07 AM GMTNew Delhi: The billionaire entrepreneur, Dilip Shanghvi, founder of the 1983 established drug giant Sun Pharmaceuticals (Sun Pharma) is striving to...
Dilip Shanghvi plans comeback; Sun Pharma to develop its own medicines: Report Meghna A Singhania26 May 2019 12:43 PM GMTShanghvi estimates that Sun Pharma has invested about $1 billion in its patented-drug programme so far. He says growth in the Indian generics...
GSK reintroduce incentives for sales representatives Farhat Nasim24 May 2019 4:01 AM GMTGSK said it would make changes to its incentive program for pharmaceutical and vaccines sales representatives, to be applied initially in the United...
Investors keep food firms on warning over antibiotics Medical Dialogues Bureau21 May 2019 3:30 AM GMTResistance to antibiotics has been flagged as a major risk to public health and economic growth by policymakers and the investor action formed part of...
Union Health Minister asked not to receive donations from JnJ for TB Control Program Medical Dialogues Bureau3 May 2019 3:45 AM GMTRecently, Johnson & Johnson (JnJ) had announced to provide an additional 10,000 courses of tuberculosis drug bedaquiline (BDQ) to the Indian...
Eli Lilly to sell legacy antibiotics brands Ceclor, Vancocin, China facility to Eddingpharm Farhat Nasim23 April 2019 4:15 AM GMTINDIANAPOLIS: Eli Lilly and Company today announced that it has entered into an agreement to sell the rights in China for two legacy Lilly antibiotic...
E-platform M3 acquires majority share in Neuroglia Health Private Limited Garima23 April 2019 4:00 AM GMTNew Delhi: An online platform for medical professionals, M3, Inc. of Japan has announced the acquisition of a majority stake of India based Neuroglia...
